Ying Luo

Ying Luo is recorded as Board Member and CEO at Gyre Therapeutics, Inc. (GYRE) since May 4, 2026. Gyre Therapeutics, Inc. reported in an 8-K filed May 4, 2026 that Ying Luo was appointed Board as a Class I director, effective May 4, 2026. Gyre Therapeutics, Inc. reported in an 8-K filed May 4, 2026 that Ying Luo was appointed Chief Executive Officer and President of the Company, effective May 4, 2026. Gyre Therapeutics, Inc. reported in an 8-K filed March 2, 2026 that Ying Luo was appointed member of the board of directors. Equibles holds 5 filed executive changes naming Ying Luo; each is listed under recent activity with its source filing. Gyre Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Gyre Therapeutics, Inc. includes Charles Wu (CEO and Board Member), Dr. Han Ying (CEO), Dr. Ying Luo (CEO and Board Member) and 7 others.